Diabetologia

, Volume 33, Issue 2, pp 105–111

Examination of islets in the pancreas biopsy specimens from newly diagnosed Type 1 (insulin-dependent) diabetic patients

  • T. Hanafusa
  • A. Miyazaki
  • J. Miyagawa
  • S. Tamura
  • M. Inada
  • K. Yamada
  • Y. Shinji
  • H. Katsura
  • K. Yamagata
  • N. Itoh
  • H. Asakawa
  • C. Nakagawa
  • A. Otsuka
  • S. Kawata
  • N. Kono
  • S. Tarui
Originals

DOI: 10.1007/BF00401048

Cite this article as:
Hanafusa, T., Miyazaki, A., Miyagawa, J. et al. Diabetologia (1990) 33: 105. doi:10.1007/BF00401048

Summary

We attempted to examine the immunopathological change of the pancreatic islets of newly diagnosed Type 1 (insulin-dependent) diabetic patients and thereby to obtain useful information for the therapy of the patients. For this purpose, pancreas biopsy under laparoscopy was performed 2–4 months after the onset of Type 1 diabetes in seven newly diagnosed patients. All biopsies were performed safely without any complications. Immunohistochemical examination of the biopsy specimens revealed a marked decrease of insulin-containing cells, preservation of glucagon-containing cells, and various degrees of expression of MHC class I and class II antigens in islet cells and in endothelial cells within and around the islets. Signs of active autoimmune phenomena, e. g. lymphocytic infiltration or immunoglobulin deposition in islets, were not detected in any of these patients by light microscopical evaluation. We conclude that pancreas biopsy under laparoscopy has shown various immunological changes in the islets of newly diagnosed Type 1 diabetic patients. Pancreas biopsy, however, may not be suitable under the present protocol for the selection of patients for immunotherapy because of problems including sampling errors.

Key words

Type 1 (insulin-dependent) diabetes mellituspathologypathogenesisdiagnosispancreas biopsylaparoscopyimmunohistochemistryMHC class I antigenMHC class II antigenimmunotherapy

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • T. Hanafusa
    • 1
  • A. Miyazaki
    • 1
  • J. Miyagawa
    • 1
  • S. Tamura
    • 1
  • M. Inada
    • 1
  • K. Yamada
    • 2
  • Y. Shinji
    • 3
  • H. Katsura
    • 1
  • K. Yamagata
    • 1
  • N. Itoh
    • 1
  • H. Asakawa
    • 1
  • C. Nakagawa
    • 1
  • A. Otsuka
    • 1
  • S. Kawata
    • 1
  • N. Kono
    • 1
  • S. Tarui
    • 1
  1. 1.The Second Department of Internal MedicineOsaka University Medical SchoolOsaka
  2. 2.Department of Medicine, Division of Endocrinology and MetabolismKurume University School of MedicineKurume
  3. 3.Nishinomiya Prefectural HospitalHyogoJapan